Company Update1 Min Read InvestyWise NewsonFebruary 6, 2026 Afcons Leadership Transition in Oil & Gas Business Unit Afcons Infrastructure Limited has announced a leadership transition within its Oil & Gas Business Unit. Ashwini Kumar Venkatesh will step…
Company Update2 Min Read InvestyWise NewsonFebruary 6, 2026 Karur Vysya Bank Inaugurates 900th Branch in Tondiarpet, Chennai Karur Vysya Bank (KVB) has inaugurated its 900th branch in Tondiarpet, Chennai. The branch was inaugurated by Mr. Ramesh Babu, Managing…
Board Meeting1 Min Read InvestyWise NewsonFebruary 6, 2026 MRF Limited Declares Interim Dividend and Announces Q3 2026 Results MRF Limited announced its Q3 2026 results, reporting revenue from operations of ₹7,933.69 crores. The Board declared an interim dividend of ₹3…
Board Meeting1 Min Read InvestyWise NewsonFebruary 6, 2026 Blue Jet Healthcare Board to Consider Financial Results on February 13, 2026 Blue Jet Healthcare has announced a board meeting scheduled for February 13, 2026, to approve the unaudited standalone financial results for…
Company Results2 Min Read InvestyWise NewsonFebruary 6, 2026 MRF Limited Declares Interim Dividend Amid Unaudited Q3 2026 Results MRF Limited has announced its unaudited financial results for the quarter ended December 31, 2025, along with a second interim dividend of Rs.…
Board Meeting1 Min Read InvestyWise NewsonFebruary 6, 2026 INOXCVA Board Meeting Scheduled to Approve Q3 2026 Results INOXCVA has announced a board meeting scheduled for February 12, 2026, to consider and approve the unaudited standalone and consolidated…
Company Update2 Min Read InvestyWise NewsonFebruary 6, 2026 Jubilant Pharmova Q3 FY2026 Results Show 17% Revenue Growth Jubilant Pharmova reported a 17% increase in revenue, reaching ₹2,123 Cr for Q3 FY2026, driven by CDMO sterile injectables. EBITDA increased…
Company Update2 Min Read InvestyWise NewsonFebruary 6, 2026 PB Fintech Q3 FY26 Earnings Call Highlights Strong Growth & Strategic Vision PB Fintech reported a 45% YoY growth in total premium for Q3 FY26, driven by a 68% YoY increase in new protection premium. PAT surged by 165%…
Company Results2 Min Read InvestyWise NewsonFebruary 6, 2026 Jubilant Pharmova Board Approves Unaudited Financial Results for Q3 2026 Jubilant Pharmova’s Board of Directors approved the unaudited standalone and consolidated financial results for the quarter and nine…
Board Meeting1 Min Read InvestyWise NewsonFebruary 6, 2026 Jubilant Pharmova Board Approves Unaudited Financial Results for Q3 2026 Jubilant Pharmova’s Board of Directors approved the unaudited financial results for the quarter and nine months ended December 31, 2025.…